254 related articles for article (PubMed ID: 24417932)
21. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
Subaiya S; Tabu C; N'ganga J; Awes AA; Sergon K; Cosmas L; Styczynski A; Thuo S; Lebo E; Kaiser R; Perry R; Ademba P; Kretsinger K; Onuekwusi I; Gary H; Scobie HM
PLoS One; 2018; 13(7):e0199786. PubMed ID: 29965975
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of antibodies against measles, mumps and rubella in Israeli young adults.
Danon YL; Adir Y; Abend I; Zaaide Y; Green MS
Isr J Med Sci; 1992 Oct; 28(10):733-6. PubMed ID: 1399506
[No Abstract] [Full Text] [Related]
23. [Recognition and immunoprophylaxis of measles and rubella].
Zhang B; Ma L
Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):698-700. PubMed ID: 32842396
[TBL] [Abstract][Full Text] [Related]
24. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
Dennehy PH; Saracen CL; Peter G
Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
[TBL] [Abstract][Full Text] [Related]
25. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation.
Pauksen K; Duraj V; Ljungman P; Sjölin J; Oberg G; Lönnerholm G; Fridell E; Smedmyr B; Simonsson B
Bone Marrow Transplant; 1992 Jun; 9(6):427-32. PubMed ID: 1628126
[TBL] [Abstract][Full Text] [Related]
26. A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children.
Sepúlveda-Amor J; Valdespino-Gómez JL; García-García Mde L; Bennett J; Islas-Romero R; Echaniz-Aviles G; de Castro JF
Vaccine; 2002 Jun; 20(21-22):2790-5. PubMed ID: 12034106
[TBL] [Abstract][Full Text] [Related]
27. The national measles and rubella campaign--one year on.
Commun Dis Rep CDR Wkly; 1995 Nov; 5(45):237. PubMed ID: 8541943
[No Abstract] [Full Text] [Related]
28. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
Kremer JR; Schneider F; Muller CP
Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
[TBL] [Abstract][Full Text] [Related]
29. The strategy for prevention of measles and rubella prevalence with measles-rubella (MR) vaccine in Japan.
Ihara T
Vaccine; 2009 May; 27(24):3234-6. PubMed ID: 19366578
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran.
Pourabbas B; Ziyaeyan M; Alborzi A; Mardaneh J
Int J Infect Dis; 2008 Jan; 12(1):43-6. PubMed ID: 17950020
[TBL] [Abstract][Full Text] [Related]
31. Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities: A multistage random cluster sampling study with mathematical modelling.
Hachiya M; Vynnycky E; Mori Y; Do HT; Huynh MK; Trinh LH; Nguyen DD; Tran NAT; Hoang TT; Hoang HHT; Vo NDT; Le TH; Ichimura Y; Miyano S; Okawa S; Thandar MM; Yokobori Y; Inoue Y; Mizoue T; Takeda M; Komada K
Int J Infect Dis; 2024 Jul; 144():107053. PubMed ID: 38641317
[TBL] [Abstract][Full Text] [Related]
32. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
Newtonraj A; Vincent A; Selvaraj K; Manikandan M
Rural Remote Health; 2019 Sep; 19(3):5261. PubMed ID: 31529972
[TBL] [Abstract][Full Text] [Related]
33. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.
Uddin MJ; Adhikary G; Ali MW; Ahmed S; Shamsuzzaman M; Odell C; Hashiguchi L; Lim SS; Alam N
BMC Infect Dis; 2016 Aug; 16():411. PubMed ID: 27519586
[TBL] [Abstract][Full Text] [Related]
35. [Changes in measles, mumps and rubella (MMR) immunity until the year of 2002 after the introduction of MMR vaccination].
Rønne T; Trier H
Ugeskr Laeger; 1992 Jul; 154(29):2014-8. PubMed ID: 1509567
[TBL] [Abstract][Full Text] [Related]
36. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.
Rafiei Tabatabaei S; Esteghamati AR; Shiva F; Fallah F; Radmanesh R; Abdinia B; Shamshiri AR; Khairkhah M; Shekari Ebrahimabad H; Karimi A
Arch Iran Med; 2013 Jan; 16(1):38-41. PubMed ID: 23273235
[TBL] [Abstract][Full Text] [Related]
37. [Susceptibility to measles, rubella and parotitis in young adults].
Bayas JM; Vilella A; Vidal J; Nebot X; Carbó JM; Navarro G; Prat A; Asenjo MA; Salleras L
Med Clin (Barc); 1996 Apr; 106(15):561-4. PubMed ID: 8656753
[TBL] [Abstract][Full Text] [Related]
38. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
[TBL] [Abstract][Full Text] [Related]
39. [Immunity coverage against measles, rubella and parotiditis viruses in a juvenile population in Leon, Spain].
Suárez J; Castañeda MR; Gutiérrez CB; Rodríguez Barbosa JI; Tascón RI; Rodríguez Ferri EF
Med Clin (Barc); 1993 Oct; 101(13):484-7. PubMed ID: 8231381
[TBL] [Abstract][Full Text] [Related]
40. Assessment of susceptibility to measles and rubella.
Preblud SR; Gross F; Halsey NA; Hinman AR; Herrmann KL; Koplan JP
JAMA; 1982 Feb; 247(8):1134-7. PubMed ID: 7057602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
